The tokenization initiative would be made in connection with a real estate project with a projected sales revenue exceeding US$400 millionBANGKOK, July 01, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that its subsidiary, NewGenDigital Limited (“NewGenDigital”), has formally secured a strategic plot of land in Ras Al Khaima ...

The Company’s initial investment into the Emirate of Ras Al Khaimah comes ahead of major tourism and infrastructure developmentsNewGen plans to diversify via additional real estate investments in Abu Dhabi pending potential transactions to provide additional capital BANGKOK, June 12, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today annou ...

NewGen’s significant expansion of its digital asset portfolio demonstrates its continued commitment to the blockchain technology sectorBANGKOK, June 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced plans to invest US$30 million in staking the digital asset Solana, marking a substantial expansion of the company’s digital ass ...

First Fertility PGS Center Limited launches culturally tailored fertility services in Thailand's growing medical tourism sectorBANGKOK, May 27, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that its wholly owned subsidiary, First Fertility PGS Center Limited (“First Fertility”), has launched a strategic expansion initiative ...

MicroSort® has been rebranded as NewGenSort as the technology becomes a more integral part of NewGen's product offerings BANGKOK, May 07, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on the integration of its recently acquired MicroSort technology. The strategic integration of this technology – which the company h ...

文章核心观点 公司宣布实施10比1的反向股票分割，5月5日起在纳斯达克全球市场以新CUSIP号按反向分割后基础交易 [1][2] 反向股票分割详情 - 实施10比1的反向股票分割，将公司已发行和未发行股份进行合并 [1] - 5月5日交易开始时，公司A类普通股将按反向分割后基础以现有代码“NIVF”在纳斯达克全球市场交易，新CUSIP号为G0544E121 [2] - 反向分割后，公司A类普通股流通股数量将从7,302,819股减至约730,282股，每10股合并为1股，不发行零碎股 [3] - 反向分割后，公司所有期权、认股权证和其他可转换证券将按计划、协议或安排条款调整，将可行使或转换的A类普通股数量除以10并四舍五入为整数 [4] 公司介绍 - 公司是亚洲综合生育服务提供商，帮助夫妇和个人获得生育治疗，致力于增加不孕治疗机会并提供综合生育服务 [5] - 管理团队在生育行业有超十年经验，诊所位于泰国、柬埔寨和吉尔吉斯斯坦，提供不孕和辅助生殖技术治疗、卵子和精子捐赠及代孕等服务 [5] 投资者关系联系方式 - 联系机构为ICR, LLC，联系人Robin Yang，电话+1 (212) 537-4406，邮箱Newgenivf.IR@icrinc.com [7]

BANGKOK, April 22, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 22, 2025 Eastern Time. The annual report can be accessed on the Company’s investor relations website at https://inv ...

公司股份发行与流通情况 - 截至2024年4月3日，公司已发行并流通的普通股数量为10,149,386股[32] - 截至报告日期，公司被授权发行最多101,000,100股无面值股份，包括100,000,000股A类普通股、100股B类普通股和1,000,000股优先股[42] - 截至2024年4月3日，业务合并完成后，有10,149,386股A类普通股流通在外，还有8,319,988份认股权证流通在外，每份认股权证可按每股11.50美元的价格购买一股A类普通股[42] 公司股权结构 - 截至2024年4月3日，方喜如（Fong, Hei Yue Tina）持有2,326,000股，占比22.9%；萧永峰（Siu, Wing Fung Alfred）持有1,779,500股，占比17.5%；Chardan Capital Market, LLC持有1,569,000股，占比15.5%等[33] - 截至2024年4月3日，所有董事和高管作为一个群体持有4,105,500股，占比40.4%[33] 认股权证情况 - 业务合并完成后，有8,319,988份公司认股权证流通在外，认股权证将于2024年5月3日可行使，2029年4月3日到期[60] 审计师变更 - 业务合并完成后，Onestop被聘请为公司的独立审计师，Marcum Asia于2024年4月3日被解聘[66] 审计报告相关 - Marcum Asia对A SPAC I Acquisition Corp.截至2023年12月31日和2022年12月31日以及2023年12月31日止两年期间的财务报表的审计报告包含有关持续经营重大疑虑的解释性段落[67] - 在2023年12月31日和2022年12月31日止年度以及至业务合并生效日期，公司与Marcum Asia在会计原则或做法、财务报表披露、审计范围或程序等事项上没有“分歧”和“可报告事件”[68] - 2023年12月31日和2022年12月31日年底及生效日期前，上市公司及其代表未就会计原则应用或审计意见咨询Onestop[69] - 上市公司向Marcum Asia提供报告披露副本，要求其致信美国证券交易委员会表明是否同意报告陈述，Marcum Asia于2024年4月9日致信的副本作为附件15.1附于报告[70] 证券上市情况 - 公司A类普通股在纳斯达克全球市场以“NIVF”为代码上市，认股权证在纳斯达克资本市场以“NIVFW”为代码上市[39][41] 财务报表引用 - ASCA 2023年年报（2024年3月29日提交给美国证券交易委员会）中F - 1至F - 21页的披露内容，包括2023年和2022年经审计的财务报表，通过引用并入本文[75] 合并协议签订情况 - 2023年2月15日，ASCA、NewGenIvf Limited等多方签订合并协议[76] - 2023年6月12日，上述多方签订合并协议的第一修正案[76] - 2023年12月6日，上述多方签订合并协议的第二修正案[76] - 2024年3月1日，上述多方签订合并协议的第三修正案[76] 其他协议签订情况 - 2024年2月29日，ASCA、上市公司等签订证券购买协议[77] - 2024年3月1日，ASCA、Legacy NewGenIvf和Chardan签订确认协议[77] 报告签署情况 - 报告于2024年4月9日由首席执行官Wing Fung Alfred Siu代表NewGenIvf Group Limited签署[79]

Initial focus includes NewGen’s expansion into UAE, with further growth initiatives to followBANGKOK, April 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has secured $5.2 million in strategic funding through two separate arrangements with an investor (“the investor”), with the potential to raise a total of up to ...

BANGKOK, March 31, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has terminated the binding term sheet with healthcare company European Wellness Investment Holdings Limited ("EWIHL") regarding their previously announced reverse merger transaction. On December 11, 2024, the Company announced its entry into a binding te ...